Literature DB >> 26292780

Failure mode and effects analysis of witnessing protocols for ensuring traceability during IVF.

Laura Rienzi1, Fiorenza Bariani2, Michela Dalla Zorza3, Stefania Romano4, Catello Scarica4, Roberta Maggiulli4, Alessandro Nanni Costa2, Filippo Maria Ubaldi4.   

Abstract

Traceability of cells during IVF is a fundamental aspect of treatment, and involves witnessing protocols. Failure mode and effects analysis (FMEA) is a method of identifying real or potential breakdowns in processes, and allows strategies to mitigate risks to be developed. To examine the risks associated with witnessing protocols, an FMEA was carried out in a busy IVF centre, before and after implementation of an electronic witnessing system (EWS). A multidisciplinary team was formed and moderated by human factors specialists. Possible causes of failures, and their potential effects, were identified and risk priority number (RPN) for each failure calculated. A second FMEA analysis was carried out after implementation of an EWS. The IVF team identified seven main process phases, 19 associated process steps and 32 possible failure modes. The highest RPN was 30, confirming the relatively low risk that mismatches may occur in IVF when a manual witnessing system is used. The introduction of the EWS allowed a reduction in the moderate-risk failure mode by two-thirds (highest RPN = 10). In our experience, FMEA is effective in supporting multidisciplinary IVF groups to understand the witnessing process, identifying critical steps and planning changes in practice to enable safety to be enhanced.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FMEA; IVF; embryos; mismatch; traceability; witness

Mesh:

Year:  2015        PMID: 26292780     DOI: 10.1016/j.rbmo.2015.06.018

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  6 in total

1.  A mixed-methods process evaluation of Family Navigation implementation for autism spectrum disorder.

Authors:  Sarabeth Broder-Fingert; Sarah Qin; Julia Goupil; Jessica Rosenberg; Marilyn Augustyn; Nate Blum; Amanda Bennett; Carol Weitzman; James P Guevara; Ada Fenick; Michael Silverstein; Emily Feinberg
Journal:  Autism       Date:  2018-11-08

2.  Fertility technologies and how to optimize laboratory performance to support the shortening of time to birth of a healthy singleton: a Delphi consensus.

Authors:  Giovanni Coticchio; Barry Behr; Alison Campbell; Marcos Meseguer; Dean E Morbeck; Valerio Pisaturo; Carlos E Plancha; Denny Sakkas; Yanwen Xu; Thomas D'Hooghe; Evelyn Cottell; Kersti Lundin
Journal:  J Assist Reprod Genet       Date:  2021-02-18       Impact factor: 3.412

3.  Clinical observations and a ealthcare ailure ode and ffect nalysis to identify vulnerabilities in the security and accounting of medications in Ontario hospitals: a study protocol.

Authors:  Maaike de Vries; Mark Fan; Dorothy Tscheng; Michael Hamilton; Patricia Trbovich
Journal:  BMJ Open       Date:  2019-06-29       Impact factor: 2.692

4.  A Preliminary Experience of Integration of an Electronic Witness System, its Validation, Efficacy on Lab Performance, and Staff Satisfaction Assessment in a Busy Indian in vitro Fertilization Laboratory.

Authors:  Sweta Gupta; Ashish Fauzdar; Vikram Jeet Singh; Ajay Srivastava; Kamlesh Sharma; Sabina Singh
Journal:  J Hum Reprod Sci       Date:  2020-12-28

5.  A Customized Tool of Incident Reporting for the Detection of Nonconformances at a Single IVF Center: Development, Application, and Efficacy.

Authors:  Daria Morini; Jessica Daolio; Alessia Nicoli; Gaetano De Feo; Barbara Valli; Beatrice Melli; Arua Sibahi; Maria Lucrezia Tranquillo; Cecilia Mezzadri; Pietro Ragni; Lorenzo Aguzzoli; Maria Teresa Villani
Journal:  Biomed Res Int       Date:  2021-10-21       Impact factor: 3.411

6.  Comparison of electronic versus manual witnessing of procedures within the in vitro fertilization laboratory: impact on timing and efficiency.

Authors:  Rebecca Holmes; Kelly Athayde Wirka; Allison Baxter Catherino; Brooke Hayward; Jason E Swain
Journal:  F S Rep       Date:  2021-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.